home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 20, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

Cygnus Technologies, LLC

4332 Southport Supply Road SE
Southport, 28461
United States of America, North Carolina

Phone: 910-454-9442
Fax: 910-454-9443

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Cygnus Technologies supplies specialized analytical products to the biopharmaceutical industry for use in process development and quality control. As recognized experts in bioprocess impurity testing for analytes such as host cell proteins, Cygnus offers a broad menu of ready-to-use ELISA kits, reagents, and analytical services, custom process-specific antibodies and assays. Cygnus manufactures generic and  process-specific / platform host cell protein ELISAs: CHO, E. coli, SP2/0, NS/0, BHK, MDCK, MRC5, Vero Cell, HEK293, CAP®, PER.C6®, HeLa, A549, and SF9. The company also offers bioprocess impurity ELISAs such as Insulin, BSA and Protein A. Custom development services for process specific impurities include: Antibody Generation- affinity purification and characterization, Assay Development- qualification by ICH guidelines, and Orthogonal Method Analysis- 2D PAGE, AAE, & Mass. Spec.

Selected Categories:

Product Company   Service Company
Biopharma
- General
Biotech
- General
Diagnostics
- Immunoassay
- in vitro
Pharmaceutical
- General
Contract
- Services
Laboratory
- Analytical

Last update of this entry: June 12, 2018

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.